The first set of proposed regulations targeting surprise medical bills gets released; faster-than-inflation Rx price hikes cost Medicare billions; healthcare spending experiences a COVID rebound; and, a new campaign aimed at kidney care is launched.
The Supreme Court hands down its latest Affordable Care Act decision; lawmakers focus on advancing critical telehealth legislation; an innovative partnership is announced to address rising generic drug prices; and, the pandemic swells Medicaid rolls.
The Supreme Court hands down its latest Affordable Care Act decision; lawmakers focus on advancing critical telehealth legislation; an innovative partnership is announced to address rising generic drug prices; and, the pandemic swells Medicaid rolls.
Stakeholders continue to highlight the value of Medicaid; top hospitals are found to charge a significant markup, as their predatory billing practices also come under increased scrutiny; and, a behind-the-scenes look at how PBMs work to save consumers money.
Lawmakers propose bills to ease telehealth access; COVID-related price-gouging still an issue; fewer independent physicians remain as hospitals gobble up private practices; and, stakeholders make price transparency tools increasingly available to consumers.
Thousands of Health Action Network members take action on the “Rebate Rule”; stakeholders support audio-only telehealth; specialty drugs make up half of all pharmacy spending; and, one of the country’s largest hospital systems sues thousands of patients.
COVID testing has become a windfall for providers; a new survey takes a look at the state of mental health; how spending on prescription drugs has changed under the pandemic; and, half of voters say curbing drug prices should be a priority for Congress.
Surprise medical billing is shown to drive up premiums for everyone; a new report shows how much more we’re paying for drugs in the U.S.; the rising cost of care is linked to health system consolidation; and, stakeholders bridge the critical gaps in maternal health.
A relatively small number of drugs are found to drive up Medicare drug spending; stakeholders urge Congress to repeal the harmful rebate rule; payers operationalize resources for the ongoing special enrollment period on the exchanges; and, our definition of social determinants of health expands to better account for drivers of poor health outcomes.
A new analysis undermines one of Big Pharma’s biggest justifications; ER docs surprise bill patients as much as ten times more; lawmakers work to advance an important audio-only telehealth proposal; and, stakeholders focus on the importance of population health.